Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Pharmaceutics|February 25, 2023
Fighting Epilepsy with Nanomedicines-Is This the Right Weapon?Mariana Matias, Adriana O Santos, Samuel Silvestre, et al.International Journal of Environmental Research and Public Health|March 25, 2022
Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance SystemCristina Monteiro, Samuel Silvestre, Ana Paula Duarte, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|March 19, 2020
From Xanthine Oxidase Inhibition to <i>In Vivo</i> Hypouricemic Effect: An Integrated Overview of <i>In Vitro</i> and <i>In Vivo</i> Studies with Focus on Natural Molecules and AnaloguesJoão L Serrano, Joana Figueiredo, Paulo Almeida, et al.Journal of Clinical Medicine|December 9, 2023
Medication and the Risk of Falls: An Analysis of Adverse Drug Reactions Reported to the Portuguese Pharmacovigilance SystemDaniela Rodrigues, Samuel Silvestre, Cristina Monteiro, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 31, 2014
HepaRG cell line as an in vitro model for screening drug-drug interactions mediated by metabolic induction: amiodarone used as a model substanceAna Ferreira, Márcio Rodrigues, Samuel Silvestre, et al.Molecules (Basel, Switzerland)|January 11, 2022
Development of Phenothiazine Hybrids with Potential Medicinal Interest: A ReviewMarina C Posso, Fernanda C Domingues, Susana Ferreira, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 19, 2017
Early preclinical evaluation of dihydropyrimidin(thi)ones as potential anticonvulsant drug candidatesMariana Matias, Gonçalo Campos, Samuel Silvestre, et al.Journal of Analytical Methods in Chemistry|January 25, 2017
Diosgenin: Recent Highlights on Pharmacology and Analytical MethodologyMafalda Jesus, Ana P J Martins, Eugenia Gallardo, et al.Molecules (Basel, Switzerland)|April 30, 2021
Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico ApproachesPedro Cruz-Vicente, Luís A Passarinha, Samuel Silvestre, et al.International Journal of Molecular Sciences|February 10, 2024
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?Ângela Gonçalves, Mariana Matias, Jorge A R Salvador, et al.Pageof 5